Evidence map›Paper›PMID 42283324›Full record

ArticleBiology open2026

The zinc contraceptive effect: targets, timing, and quantitative thresholds.

Kirsten Shankie-Williams, Margot Day, Samson Dowland

Abstract read
In one paragraph

Article in Biology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kirsten Shankie-WilliamsSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0001-6055-8805
Margot DaySchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
Samson DowlandSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

Funding

University of Sydney
6 · The paper itself

Abstract

There is a critical need for novel non-hormonal contraceptives. Zinc-based intrauterine devices (IUDs) demonstrate 100% efficacy in rats, yet the mechanism remains unclear. We investigated whether zinc targets sperm, embryos, or the endometrium. Rats with zinc, copper, or nylon IUDs were mated. All retrieved embryos were fertilised, indicating no primary spermicidal effect. However, embryos from rats with a zinc IUD failed to reach the blastocyst stage, unlike those from rats with a copper IUD. In vitro embryo culture confirmed that zinc significantly inhibited mouse embryo development in a dose-dependent manner, with 5 μg/ml zinc causing a 97% decrease in blastocyst formation, whilst copper caused a 61% decrease. Surviving zinc-treated embryos also had significantly reduced attachment to human endometrial cells, unlike copper-treated embryos. There was also no reduced attachment of untreated mouse embryos to zinc- and copper-treated endometrial cells. These findings suggest that zinc's primary contraceptive mechanism is the potent inhibition of pre-implantation embryo development.

Indexed as

Contraceptive AgentsZincAnimalsBlastocystEmbryo ImplantationEmbryonic DevelopmentEndometriumFemaleHumansMaleMiceRatsSpermatozoaContraceptive AgentsZincContraceptionEmbryoMechanismZinc

Identifiers

PMID42283324
PMCPMC13383112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.